The landscape after PEACE: do all ACE inhibitors act in an identical way?

References

• Braunwald E, Domanski MJ, Fowler SE, et al. [PEACE Trial Investigators]. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. New Engl J Med 2004;351: 2058–68
   Google Scholar
• CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New Engl J Med 1987;316:1429–35
   Google Scholar
• Swedberg K, Kjekshus J, Snapinn S. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. Eur Heart J 1999;20:136–9
   Google Scholar
• Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial [The SAVE Investigators]. New Engl J Med 1992;327:669–77
   Google Scholar
• Rutherford JD, Pfeffer MA, Moye LA, et al. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial [SAVE Investigators]. Circulation 1994;90:1731–8
   PubMed Web of Science ®Google Scholar
• The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New Engl J Med 1991;325:293–302
   PubMed Web of Science ®Google Scholar
• The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New Engl J Med 1992;327:687–91
   Google Scholar
• Yusuf S, Pepine CJ, Garces C, et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992;340:1173–8
   PubMed Web of Science ®Google Scholar
• The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821–8
   Google Scholar
• Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction [Trandolapril Cardiac Evaluation (TRACE) Study Group]. New Engl J Med 1995;333:1670–6
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin- converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [The Heart Outcomes Prevention Evaluation Study Investigators]. New Engl J Med 2000;342: 145–53
   PubMed Web of Science ®Google Scholar
• Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782–8
   Google Scholar
• Jong P, Yusuf S, Rousseau MF, et al. Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. Lancet 2003;361: 1843–8
   PubMed Web of Science ®Google Scholar
• ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. Lancet 1995;345: 669–86
   Google Scholar
• Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115–22
   PubMed Web of Science ®Google Scholar
• Oosterga M, Voors AA, Pinto YM. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study) [QUinapril on Vascular Ace and Determinants of Ischemia]. Am J Cardiol 2001;87: 542–6
   Google Scholar
• Kjoller-Hansen L, Steffensen R, Grande P. The Angiotensin- converting Enzyme Inhibition Post Revascularization Study (APRES). J Am Coll Cardiol 2000;35:881–8
   PubMed Web of Science ®Google Scholar
• Pitt B. ACE inhibitors for patients with vascular disease without left ventricular dysfunction – may they rest in PEACE? New Engl J Med 2004;351:2115–7
   PubMed Web of Science ®Google Scholar
• Pitt B, O’Neill B, Feldman R, et al. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol 2001;87:1058–63
   PubMed Web of Science ®Google Scholar
• Furberg CD, Pitt B. Are all angiotensin-converting enzyme inhibitors interchangeable? J Am Coll Cardiol 2001;37:1456–560
   PubMed Web of Science ®Google Scholar
• Siscovick DS, Raghunathan TE, Psaty BM. Diuretic therapy for hypertension and the risk of primary cardiac arrest. New Eng J Med 1994;330:1852–7
   Google Scholar
• Freemantle N, Calvert M, Wood J, et al. Composite outcomes in randomized trials: greater precision but with greater uncertainty? J Am Med Assoc 2003;289:2554–9
   PubMed Web of Science ®Google Scholar
• Fox KF. Management of coronary artery disease: implications of the EUROPA trial. Br J Cardiol 2004;11:195–204
   Google Scholar
• Moye LA. Statistical reasoning in medicine: the intuitive p-value primer. Springer-Verlag: 2000. pp. 130–1
   Google Scholar
• PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–41
   PubMed Web of Science ®Google Scholar
• MacMahon S, Chalmers J. Blood pressure lowering and ACE inhibition for the avoidance of cardiac and cerebral events. Eur Heart J 2003;24:391–3
   PubMed Web of Science ®Google Scholar
• Rakugi H, Wang DS, Dzau VJ, et al.. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 1994;90;449–55
   PubMed Web of Science ®Google Scholar
• Mancini GB, Henry GC, Macaya C, et al. Angiotensin- converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996;94:258–65
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Dzavik V, et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001;103:919–25
   PubMed Web of Science ®Google Scholar